ADR News Bulletin 2019 September (Volume 21 Number 2)

Bulletin Highlights:

  • Risk of serious liver injury with Esmya® (ulipristal acetate)
  • AE Case in Focus: Test Yourself
  • Biotin interference with clinical laboratory tests
  • Risk of acute pancreatitis and congenital malformations associated with the use of carbimazole or thiamazole
  • What to do if you suspect a product defect
  • Regulatory update on biosimilars
  • List of Dear Healthcare Professional Letters
  • Answers to AE Case in Focus: Test Yourself

Click on the link below to download the issue in pdf:

ADR_News_Sep2019_Vol21_No2730 KB

Healthcare professional, Industry member, Therapeutic Products
Published:

Adverse Drug Reaction News Bulletins

4 Dec 2019
Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.